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Decentering health research networks: framing collaboration in the context of narrative 
incompatibility and regional geo-politics 
 
Introduction  
 
Research policies increasingly see technological innovations and research breakthroughs as 
realised through the formation of collaborative networks between State and non-State actors; 
commonly described as a ‘triple-helix’ between industry, universities and government 
(Bozeman 2000; Etzkowitz and Leydesdorff 2000; Gibbons 1994; Powell et al 1996). Such 
collaborations are exemplified in bio-medical, clinical and health services research where 
government funders, university academics, bio-tech industries and service providers work 
together to develop, trial and implement evidence-based therapies and interventions. A major 
factor in the promotion of collaborative research networks is the recognition that evidence-
based interventions do not easily ‘translate’ into frontline care; with reports describing time-
lags of up to 15 years (Grimshaw et al. 2012). In some cases, delays ensure the safety of new 
therapies, but where they become too long and systemic there is potential for wasted 
investment and prolonged delivery of sub-optimal care. Such time-lags have been interpreted 
as ‘translation gaps’ between the discovery of basic science and its application (T1) in 
product testing, and then between proven interventions being implemented (T2) into routine 
practice (Cooksey 2006). The networked model of health research aims to close these gaps by 
building closer links between knowledge producers and service users in the co-production of 
evidence-based interventions.  
 
In the UK, a variety of networked research infrastructure has been established to close the 
translation gaps in health research, such as Biomedical Research Centres (BRCs) and 
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Academic Health Science Networks (AHSNs). In this paper, we examine the introduction of 
Collaborations for Leadership in Applied Health Research and Care (CLAHRCs) as regional 
multi-agency research networks.  In 2008, nine ‘pilot’ CLAHRCs were introduced across 
England to bring together university researchers, NHS leaders, and other public stakeholders 
to undertake ‘applied health research’ (T2), i.e. research that can directly impact on the way 
services are organised and delivered. A ‘second wave’ of 13 CLAHRCs was introduced in 
2014, which provide the focus for our study. These initiatives received in excess of £200m 
public research funding, with ‘match funding’ from NHS, industry and university partners. 
Although questions remain about their contributions to frontline services (Kislov et al. 2018), 
further funding was announced in late 2018 for a similar ‘translational’ research programme.  
 
Research shows the formation of early CLAHRCs was shaped by how different healthcare 
and research leaders translated national policy in the context of local historical contingencies 
and competing local priorities (Caldwell and Mays 2012; Locket et al. 2014; Rycroft-Malone 
et al. 2013). Building on these ideas, our study looks closer at how local actors resolve the 
dilemmas of reconciling three (often competing) policy narratives, first, to carry out world-
class research; second, to ensure research meets local needs; and third, to develop new 
understanding about the implementation of research into practice. Although this collaborative 
agenda might appear coherent to ‘elite’ national policy-makers, at the regional level it 
provides the basis for disagreement and negotiation amongst university researchers and 
service providers and commissioners. 
 
Just as the health services research communities have come to realise the translation and 
implementation of evidence into practice is often complicated, the interpretative policy 
literature shows how national public policies are rarely, if ever, neatly implemented into local 
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service organisation and delivery (Yanow 1996). Rather, they are subject to on-going re-
interpretation and modification as they are translated and enacted in different arenas (Lipsky 
1968). To explore how health research policies are translated and implemented we take a 
‘decentred’ approach, as developed by Bevir and colleagues (Bevir, 2011: Bevir and 
Richards, 2009). The decentred approach attends to the ways governance arrangements are 
realised through, and are contingent upon, the interactions and meaningful practices of policy 
actors. These meaningful practices are guided by actors’ beliefs and customs that are rooted 
in different ‘traditions’. At the same time, these practices are the source of novel governance 
arrangement as actors confront ‘dilemmas' when interpreting and enacting policies, for 
example where existing meanings and beliefs are contradictory or perceived as irreconcilable.    
 
The decentred approach pays particular attention to the role of narratives in both informing, 
and unsettling, meaningful practice (Bevir 2011). Narratives are understood as relatively 
coherent stories of problem-definition and problem-resolution that reflect prevailing systems 
of meaning and belief (Fisher 2010). From the decentred perspective, narratives are both a 
source of tradition, i.e. stories about how services have worked, and a source of dilemma, i.e. 
when new policy narratives attempt to reshape local practices. In the context of such 
dilemmas, localised governance arrangements are formed as policy actors seek to reconcile 
competing or contradictory narratives through their meaningful practices. The decentred 
approach attends, in particular, to the ways ‘elite’ policy narratives, i.e. those constructed by 
political elites and policy-makers are received, filtered and negotiated through the meaningful 
practices of local policy actors operating in the context of their local traditions and narratives. 
 
Taking a decentred approach, our paper examines the tensions between (and within) ‘elite’ 
and ‘local’ policy narratives for applied health research, and how these tensions represent 
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dilemmas around which meaningful practices translate, negotiate and enact policy into 
practice.  Later within our paper, we turn to the literature on ‘framing’ to develop our 
analysis of how policy actors, at different levels, seek to reconcile the dilemmas posed by 
divergent policy narratives. A ‘frame’ can be defined as a cognitive-cultural filter through 
which social actors perceive, organise and make sense of their experiences in the context of 
their interactions (Goffman 1974). Within social movement and policy studies, ‘framing’ 
relates to the way actors interpret and communicate a policy issue, especially when seeking to 
influence how others will interpret and respond to it (Snow and Benford 1992). In this 
respect, social actors can use ‘narratives’ or appeals to ‘tradition’ to both interpret and shape 
how people make sense of policies (Fairhurst and Sarr 1996). Although some subsume 
narratives within framing processes, Olsen suggests (2014) ‘frames’ and ‘narratives’ offer 
distinct but complementary insights, which we see as enriching a decentred approach. From a 
decentred perspective, narratives represent relatively broad discursive accounts that articulate 
particular governing rationalities (Bevir 2011), whereas framing focuses more on the 
interactive dimensions through which actors interpret and communicate policies in their 
meaningful practices. As such, we operationalise framing theory to analyse the meaningful 
practices of social actors as they confront and translate divergent policy narratives. 
 
Drawing on a historical review of recent health research policy in the UK, the paper first sets 
the context of the changing health research landscape and the emergence of a dominant ‘elite’ 
policy narrative. It then develops detailed analysis of the meaningful practice of translating 
policy in one regional context drawing on documentary, observational and interview data 
collected over five years.  Invoking the framing literature, we argue that the translation of 
policy is problematised as it passes through layers of decision-making through a process of 
‘cascade framing’, with the policy narrative being disturbed, transformed and mutated as it 
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works its way through the health research landscape.   We suggest, in particular, that ‘parallel 
frames’ can emerge that reflect the different interpretations of policy and the localised 
agendas of stakeholders. 
 
Collaborations for Applied Health Research and Care: Policy narrative  
Throughout much of the Twentieth Century, research priorities in the UK were based on the 
‘Haldane’ principle; namely, that decisions about funding should be guided by the research 
community, not politicians. In the early 1970s, the Rothschild Report recommended that 
research should more directly contribute to policy-making and, since that time, the 
politicisation of research policy has continued with the alignment of funding to national 
economic and political priorities (Parker 2016). In the health research context, this has seen 
government departments, quasi-governmental agencies, and arms-length research council, 
coming together to prioritise and fund a broad portfolio of ‘bio-medical’ and ‘clinical’ 
research for the discovery, testing and implementation of new therapeutic interventions, as 
well as ‘health services’ research concerned with analysing and evaluating new modes of 
service organisation and delivery. It is increasingly the case that such funding is shaped by 
the expectation that health research should make a meaningful and substantial contribution to 
political and economic priorities.  
 
In 2004, for instance, the UK Treasury called for health research to have greater economic 
impact through fostering partnerships between industry and clinical research teams (HM 
Treasury 2004). Similarly, the Department of Health report Best Research for Best Health 
(DoH 2006) recommended collaboration between industry, universities and NHS 
organisations to address national economic and health priorities. This included 
recommendations for streamlined research governance and funding through a National 
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Institute for Health Research (NIHR). The combined aspirations for ‘health and wealth’ have 
carried through into a succession of policies that have shaped the national policy narrative for 
collaborative research activities, including CLAHRCs. For example, following the decision 
to ring-fence health research funding through agencies such as the NIHR, the UK Treasury 
commissioned the ‘Cooksey Report’ (Cooksey 2006) to consider future funding options. This 
report is significant for highlighting the ‘first’ and ‘second’ translational ‘gaps’ in the 
research ‘pipeline’, as well as an apparent bias towards blue-sky ‘discovery’. It suggested 
“the UK is at risk of failing to reap the full economic, health and social benefits that the UK’s 
public investment in health research should generate.” (Cooksey, 2006:1). Highlighting the 
achievements of international research institutions, such as the Canadian Institute of Health 
Research (CIHR), the report called for enhanced national leadership for ‘applied’ and 
‘translational’ research based on collaborative partnerships between research and clinical 
communities. That is, collaborative research that determines how interventions, shown to be 
effective in trial conditions, can be implemented in ‘real-world’ healthcare settings.  
 
The collaborative (and economic) agenda was developed by The High-Level Group on 
Clinical Effectiveness (Tooke, 2006). This brought attention to the different rates at which 
evidence-based interventions were implemented into routine practice, and again called for 
more applied and translational research, emphasising community-wide research 
collaborations between clinicians and academic researchers and the translation of evidence 
into practice (Tooke 2006). The report was careful to define ‘applied research’ as having 
practical application for patient benefit, with the proviso that patient gain should be realised 
within three-four years. 
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It was within this context that the national policy narrative for translational health research 
centres was crafted. Significant was the framing of a particular problem related to the 
translation of biomedical and clinical research into frontline patient care because of a 
disjointed research landscape where academic research was decoupled from clinical practice 
(and industry). The narrative also raised concerns about the culture of established research 
models, which appeared to be dominated by ‘blue-sky’ university research, rather than 
‘applied’ research. Although the CLAHRC narrative is ostensibly concerned with the 
‘second’ translational gap, the underpinning policy narrative reflects wider political 
imperatives. First, there is a strong economic agenda centred on the wasted resources 
associated with the delays in implementation, and the lost potential for wealth creation from 
developing new therapies with industry. Second, is the view that the UK was falling behind 
other OECD countries and hence should emulate the successes of these world-leaders in 
introducing translational research networks (notwithstanding a lack of evidence). Third, there 
was an aspiration to transform the culture of the NHS with an emphasis on creating a 
research-led service in which both staff and patients were engaged in research.  
 
In October 2007, the NIHR called for proposals to establish research collaborations that 
would “forge a mutually beneficial, forward-looking partnership between a University and 
the surrounding NHS organisations, focused on improving patient outcomes through the 
conduct and application of applied health research”. The first CLAHRCs were framed as 
‘pilots’ and later ‘experiments’ suggesting that policy-makers were uncertain how these 
networks should be organised to ‘close the gap’ between research and practice (Rowley et al. 
2013). The call required a single NHS organisation to lead the collaboration, with the quality 
of the application assessed on the track record of ‘applied research’ with university partners. 
A significant feature was the expectation for CLAHRCs to secure ‘match-funding’ from 
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NHS, academic and industry partners to the equivalent value of NIHR funding. As well as 
designating ‘clinical’ research themes, reflecting local and national priorities, it was expected 
that at least one theme would deal with the science of ‘implementation’; that is, 
understanding how evidence can be more effectively translated into practice. In 2008, nine 
‘pilot’ CLAHRCs were established each with up to £10m funding for five years.  
 
Reflecting the idea that the initial wave of CLAHRCs were ‘experiments’, the NIHR 
commissioned a programme of formative evaluations to review how the different 
collaborations formed and to appraise their relative success in closing the second translation 
gap (Walshe and Davies 2013). The findings of these evaluations (summarised below) 
informed the ‘second call’ for CLAHRCs issued in August 2013. On this occasion, the NIHR 
announced that £124 million would be allocated for 13 new CLAHRCs. As with the first call, 
the collaborations needed to ‘close the second translation gap’, but there was more explicit 
focus on national clinical priorities for dementia, long term conditions, and public health; and 
that research should be generalisable to the wider NHS, not only local service needs. It was 
also clear that the new CLAHRCs would be tailored to the changing NHS landscape 
following the Health and Social Care Act (2012), including more focus on industry 
partnerships. The new CLAHRCs were intended to: 
 
• Develop and conduct applied health research relevant across the NHS, and to translate 
research findings into improved outcomes for patients. 
• Create a distributed model for applied health research that links those who conduct 
applied health research with all those who use it in practice. 
• Create and embed approaches to research and its dissemination that are specifically 
designed to take account of the way that health care is delivered across the local AHSN. 
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• Increase the country’s capacity to conduct high-quality applied health research focused on 
the needs of patients, and targeted at chronic disease and public health interventions. 
• Improve patient outcomes locally and across the NHS. 
• Contribute to the country’s growth by working with the life sciences industry. 
 
Of relevance to our paper, there were important changes in the policy narrative for second-
wave CLAHRCs. The first related to the need for alignment with a changing regional 
infrastructure, specifically AHSNs, that were introduced to accelerate the spread and scale-up 
of evidence-based innovations. Second, there was more explicit emphasis on the importance 
of collaborating with industry and the contribution to economic growth: “NIHR CLAHRCs 
will facilitate improved outcomes for patients and the NHS, and also contribute to the 
country’s economic growth by working with the life sciences industry” (p.3). Third, there was 
a drive towards building “a critical mass” of people engaged in applied health research, with 
stronger emphasis on the track record of ‘world class’ research teams. This involved, for 
example, numerical measure of research quality in terms of academic outputs, grant capture 
and PhD completion, which in many ways reinforced traditional university research, rather 
than translational or applied research. Fourth, NIHR funding was reserved primarily for 
‘applied research’, with the expectation that match-funding would be allocated for the 
‘implementation’ of evidence into practice, which could be seen as re-introducing a 
separation between research and implementation.  
 
The language of policy reveals various meanings of what health research ‘is’ reflecting 
different ‘scientific’ or ‘disciplinary’ traditions, i.e. ‘bio-medical’, ‘clinical’ ‘applied’ and 
‘translational’ research. In one regard, the policy narrative for both first- and second-wave 
CLAHRCs emphasises the importance of ‘applied’ and ‘translational’ research, i.e. 
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implementing and testing interventions in real-world settings that are already evidence-based. 
Yet, in other ways, assessments of research capacity and quality are based upon more 
traditional ‘bio-medical’ or ‘clinical’ lines. And at the same time, political interests continue 
to promote the importance of economic benefits and working with industry. It might be 
argued, therefore that a coalition of ‘elite’ political, industry and scientific interests shaped 
both the wider health research policy landscape and the particular CLAHRC agenda. Yet, the 
heterogeneity and incoherence between these perspectives could also be seen as creating 
dilemmas or opportunities for subsequent policy translation where local actors interpret the 
different elements of the policy narrative according to their pre-existing frames or traditions.  
 
Collaborations in context: Research commentary  
In their analysis of changing health research policy, Walshe and Davies (2013) describe 
CLAHRCs as creating a research infrastructure to meet the strategic needs for innovation 
within the NHS. Research on the first-wave CLAHRCs offers important insight into the 
translation of policy. Of note, Caldwell and Mays (2012) analyse the translation of policy 
from expert reports, through national policy-makers, to one regional CLAHRC team. Their 
review suggests there was a broad degree of alignment amongst national policy-makers and 
local CLAHRC leaders in the aspirations for translational health research.  
 
In contrast, comparative research shows CLAHRCs have translated policies along different 
lines according to regional priorities and the influence of clinical and service leaders. 
Rycroft-Malone et al. (2013) describe how differences in stakeholder engagement, funding, 
and formal governance arrangements shaped the strategies for collaboration.  Significantly, 
the local history of university/NHS collaborations pre-conditioned CLAHRC formation, 
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whilst differences in power, especially between clinical and academic groups, impacted the 
potential for collaboration (Currie et al. 2013). 
 
Similarly, Lockett et al (2014) delineate five ‘archetypes’ of the different relationships 
between research and practice. For example, the ‘modular’ archetype describes a separation 
of research and implementation activities that work in connected, but distinct domains; 
another describes CLAHRCs as ‘collaborating through loose networks’ derived from pre-
existing research partnerships between universities and healthcare organisation; whilst 
another sees CLAHRCs are characterised by ‘centrally controlled service improvement 
projects’ with a high-level core team monitoring local project teams embedded in service 
settings. More significantly, however, Lockett et al. suggest policy translation leading to 
these archetypes was shaped by prevailing ‘field’ conditions, including the history of 
university/NHS collaboration and the priority given to different types of research. They 
focus, in particular, on the influence of local leaders in framing the opportunities for applied 
research: with ‘clinical’ leaders adopting a more service-facing approach, ‘clinical-academic’ 
leaders favouring more traditional models of (trial) research, and ‘social science’ academics 
favouring implementation strategies. They argue that ‘who’ defines the problem locks in the 
resulting solution, or model of collaboration (Currie et al. 2013). 
 
In their recent review, Kislov et al. (2018) further make the point that the local context (and 
history) of relationships between NHS and research communities shapes the translation of 
policy in the regional organisation of CLAHRCs. Our paper develops a decentred analysis of 
the way national or ‘elite’ CLAHRC policies are translated into local context, focusing on the 
influence of history, dilemma and meaningful practice in the selective translation, (re-) 
framing and enactment of policy. Narratives are treated as reasoned stories that are formed in 
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the context of particular histories, traditions and interests that affect the meanings, behaviours 
and identities of social actors (Fischer 2010; Shuman 2012; Yanow 2007). They are also sites 
for conflict, as divergent traditions and meanings compete to shape social practices, and the 
dilemmas created by this conflict creates opportunities for novel forms of meaningful 
practice (Bevir 2011). For instance, elite policy narratives articulated by state actors reflect 
particular historical interests and agendas that are not always consistent in themselves or 
consistent with those of non-state actors. How local actors interpret and translate elite 
narratives in the context of their own histories creates both dilemmas and opportunities for 
meaningful agency; potentially re-making the local and resisting the elite.  
 
In the context of health research, the policy narrative can be seen as composed of multiple 
and, at times, competing scientific, political and economic imperatives that might represent 
ambiguities and inconsistencies to local actors.  For example, the perpetual quest to provide 
high quality services with limited fiscal resources. Rather than focusing on the social position 
and influence of CLARHC leaders (Lockett et al. 2014), our analysis focuses more broadly 
on how coalitions of local actors work through their divergent interpretations and negotiate 
the translation of policy in the context of local histories.  In particular, it explores how local 
narratives not only reflect (and resist) some of the expectations of national policy, but also 
represent divergent views, expectations and agendas, which find expression in the 
ambiguities and dilemmas created by policy and in the interactive practices of local actors.  
As outlined above, our analysis focuses on the ways both national and local policy narratives 
(as expressions of tradition and meaning) are articulated, enacted and resisted through the 
framing activities of different policy actors and resources (Fairhurst and Sarr 1996). In 
particular, our study considers how policy actors, at different stages of policy translation, 
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framed and re-framed the policy narrative in the process of negotiated and mediating 
divergent interests. 
 
 
Study Methods 
We initially developed a genealogy of health research policy in the UK from the late 
Twentieth century to the present, which forms the basis of the background section of this 
paper. We regard policy documents, reports and other announcements as inherently 
discursive in that they reflect and articulate particular political ideologies, modernist 
assumptions and are constitutive of relations of power (Fischer 2010; Foucault, 1984; Gale 
2001; Yanow 1996). In practical terms, this involved identification, collation, and critical 
interpretation of reports, policy documents and policy evaluations, and the underpinning 
source materials and evidence. Following Yanow (1996), these were subject to a relatively 
structured narrative analysis to delineate the key historical moments and turning-points, the 
underlying assumptions, motives and interests at play, the symbolic meanings and metaphors 
and the prescriptive elements of policy.  
 
We also carried out in-depth qualitative research with local policy actors involved in the 
formulation and implementation of one ‘second-wave’ CLAHRC, with the aim of 
understanding the local translation and enactment of policy. Given resource constraints only 
one CLAHRC could be researched over a four-year period with data collection commencing 
in the preliminary stages of CLAHRC formation and continuing until past the mid-point of 
the funded activity. The CLAHRC was selected because of its specific historical 
circumstances, which were identified as a ‘dilemma-potential’ in the translation of policy; 
namely, the CLAHRC was formed from the merger of two ‘pilot’ CLAHRCs, each with 
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different leadership arrangements, regional demographic priorities, and histories of research 
collaboration. As such, it was a relatively unique case (Stake 1995) for investigating how 
different histories within a region can shape assumptions about applied and translational 
research, the interpretation of policy and the creation of a new regional narrative.  
 
The qualitative research involved non-participant observations and semi-structured 
interviews. Over a period of nearly four years, observations were undertaken of CLAHRC 
governance and executive meetings, research theme management groups, project meetings 
and public engagement activities. In excess of 200 hours of observations were undertaken, 
with data recorded in hand written field journals. The observations revealed the interactive 
processes and negotiations through which the CLAHRC was formulated and operationalised, 
‘zooming in’ on key issues and dilemmas faced by local actors. As part of the observations a 
large number of in situ, ethnographic interviews were undertaken to explore and clarify 
observed events. In addition, semi-structured interviews were conducted with 20 individuals, 
including senior CLAHRC executives (6), administrators (3), theme leaders (4), and project 
team leads and members (7). The interviews elicited participants’ personal experiences and 
interpretations of the CLAHRC ‘story’ with a focus on how different actors translated and 
negotiated policy aspirations in the context of local histories.  
 
Summary observation records and interview transcripts were subject to interpretative 
narrative analysis (Yanow 1996) that focused on how participants reflected on the ‘story’ of 
the CLARHC, including the history of the two preceding collaborations, the processes of bid 
development, and the new arrangements for research governance and project management. In 
examining these narratives, we analysed how these stories revealed common and divergent 
meanings, beliefs and interests. In practical terms, interview transcripts were subject to close 
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reading and coding by two authors, identifying key events and issues, around which common 
and distinct ‘stories’ and prevailing ‘scripts’ were crafted. These were then discussed and 
debated with the wider study team with the goal of developing a critical interpretation of 
policy translation.   
 
 
The local experience of CLAHRC 
 
Regional legacy and parity 
 
In the months before the formal call was announced, senior research leaders within the region 
began to mobilise local collaborators in anticipation of a future CLAHRC bid. In the absence 
of policy detail, local actors were uncertain about the expected size and scope of the new 
collaboration, especially the anticipated research priorities and their relationship with the 
changed NHS infrastructure. A major issue was whether the two existing ‘pilot’ CLAHRCs 
would be permitted to continue independently, whether they should submit competing bids, 
or whether a combined application should be proposed. As such, multiple groups mobilised 
around these options in advance of ‘the call’. The eventual call required proposed 
collaborations to align with the regional AHSN ‘footprint’ making the submission of a 
combined regional bid the lead option.  
 
Through a series of preliminary ‘behind the scenes’ discussions, brokered by the managing 
director of the AHSN, with representatives from major hospitals and university research 
leaders, it was decided a single application was the most appropriate path. Quickly within this 
process, research leaders crafted a collective narrative of a ‘mature’ CLAHRC (rather than 
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‘new’) that built on the ‘track record’ of the existing ‘pilots’ to offer an unprecedented model 
of synergy and collaboration. As such, a ‘master frame’ started to emerge that played on both 
the national and regional narrative of ‘collaboration’ and helped to galvanise and coordinate 
subsequent local action. For some, however, this was more of an ‘arranged marriage’ with 
complex geo-political considerations and long-term ramifications for CLAHRC governance. 
 
‘We knew we had to be collaborative because we didn’t have the scale in [City A] or 
in [City B] or in [Town A] to do it all ourselves. And that’s the idea of it you know, 
CLAHRC stands for Collaboration.’ (NHS Partner)  
 
‘When the call came out it turned out there would be one CLAHRC per AHSN area 
and therefore a very hasty marriage was convened…. And we had a number of 
meetings over several months then to basically put together a joint CLAHRC to bid.’ 
(Academic Project Lead) 
 
In crafting this collective narrative, research leaders were attentive to the need to create an 
impression of inclusivity and parity, especially in the allocation of leadership roles and 
research projects. An early task was the selection of a new CLAHRC director. An open 
competition was announced for an experienced health services researcher with a world-class 
research profile, as demonstrated by their funding track record, publication profile and H-
index (a requirement of NIHR), and profile within the region.  The appointed leader was 
selected through an independent selection process involving national and regional NHS 
leaders. They were based in one area of the region, which prompted further questions about 
the allocation of other senior roles, such the Research Director and the Implementation Lead. 
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In making these appointments regional NHS, AHSN and university leaders continually 
sought to create a sense of fairness and inclusivity: 
 
 
‘…the main thing was to convince the funders that we had an organisation that was 
capable of meeting the brief. So, there was a fusion of the old {CLAHRC A] and the 
old [CLAHRC B]. And there was the selection of people with a good enough H-index 
to be able to be seen to lead work streams.  I’m sure that’s why… I got involved, 
mainly because I had the numbers, rather than I was necessarily all that appropriate.’ 
(Research Theme Lead) 
 
A further consideration was the selection of the research theme leaders, which in the interests 
of parity saw two leaders appointed from one existing CLAHRC and two from another. 
Selection also considered the standing of the researchers in their given field and their fit with 
national and local priorities. As elaborated in the next section, the appointment of the theme 
leaders, and the selection of the research projects developed through periods of consultation 
and engagement with local partners, in order to construct a convincing narrative for the 
research funders.  
 
‘…throughout the whole of the development, there was a sense of trying to create 
some parity of fairness between the different bits.’ (Research Theme Lead) 
 
The emerging narrative, or master frame, of the ‘mature’ CLAHRC was therefore shaped in 
the context of multiple competing agendas, including the need to demonstrate the ‘new’ 
CLAHRC was building on a proven track record to meet the expectations of national funders; 
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the need to ensure geo-political fairness to secure the financial commitment of regional 
partners; and also the need to ensure the engagement of local researchers and service 
providers. As described below, there remained tensions around what types of ‘applied’ 
research the CLAHRC would undertake and what role regional partners would have in 
shaping this work.  
 
Determining Research Priorities  
Early within the process of drafting the CLAHRC proposal, regional research leaders 
commenced a consultation exercise with local NHS commissioners, care providers, 
universities, and industry partners to determine the future research priorities. This reflected 
the policy expectation for research to address local service needs, and to demonstrate both 
engagement with and commitment from regional actors, especially in the form of ‘match-
funding’. The key priorities identified included: dealing with complex conditions, integrated 
care, access to care, inequalities / prevention, patient safety and public health.  
 
‘Part of the requirement was that participating organisations, both NHS and 
academic, need to bring in an equal amount of funding to that that was passed over 
from NIHR….that added up to several million pounds…but in doing that I guess it’s 
to a greater or lesser extent the collaborating organisations felt they had some 
ownership of the CLAHRC.’ (University Research Manager) 
 
What became immediately apparent was the gap between local and national priorities. A 
further complicating factor was the track record and trajectory of clinical research within the 
region, i.e. where researchers specialised in areas that did not necessarily align with national 
priorities. As such, the resulting plan became a compromise between meeting national 
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priorities, the local priorities of the ‘match’ funders, and the research agenda of local research 
teams. Looking at the minutes of early steering group meetings, for example, much of the 
planning centred on identifying strategic partners and ‘match funding’ over and above 
research quality or national priorities. As such, this involved crafting a further iteration of the 
CLAHRC narrative that could ‘be all things to all people’:  
 
‘So, the legacy projects carried forward into the new CLAHRC. And there were 
various criteria that we used for example to select what sort of new projects would 
make a good CLAHRC project. And were stakeholders on boards? Did you have a 
strong implementation plan? Does it align to a pre-identified health need or priority? 
(Research Manager) 
 
A call for research projects was issued across the region framed by both local and national 
priorities. Project proposals needed to fulfil the requirements of being ‘world class’ research, 
whilst testing the implementation of evidence-based interventions in multiple local services, 
and also meeting national priorities. Four overarching ‘clinical’ research themes were 
identified, and a cross-cutting ‘implementation’ theme. Looking closer at this thematic 
organisation, some themes and their projects reflected a more experimental or ‘trial’ 
methodology to determine whether a potential intervention might deliver health 
improvements; whereas others adopted a more co-produced methodology to investigate how 
a proven intervention was implemented in local settings. Although all projects involved 
detailed ‘implementation plans’, there were subtle differences in the underlying philosophies, 
with the more trial based studies led by clinical researchers and the implementation studies 
co-designed with service partners. As such, the new CLAHRC brought together different 
research traditions that did not always sit easily in terms of the overarching narrative. For 
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example, the CLAHRC scientific committee needed to be open to multiple research 
perspectives, whilst still maintaining a commitment to ‘world class’ research, which some 
saw as aligned with ‘trial’ studies.  
 
‘In an idealised world, the CLAHRC is a unique vehicle for bringing together a whole 
range of different people who want to make a difference in making healthcare better 
through actually researching … doing research on interventions, on practices, on 
procedures, on anything that can make healthcare better. And it’s almost like a hook 
or a nexus point and it brings all these people together and they should work in this 
kind of dynamic mode two way of kind of interdisciplinary problem-solving.’ 
(Research Theme Lead) 
 
The drafting of the bid involved numerous iterations and revisions, which exposed dilemmas 
in how to present and mediate the aforementioned issues. At this stage, it appeared that much 
of the work of crafting the proposal was led by one regional partner, with others offering 
comment and revision. The CLAHRC ‘mission’ was presented as making a lasting impact on 
the health of the regional population, with the applied research projects being the means by 
which this would be achieved. The bid document emphasised (in order of appearance): a) 
improved health outcomes; b) the priorities of regional care commissioners and providers; c) 
prominent regional health issues and inequalities; d) world-class research; and e) working 
with partners. This started to reveal what would become the use of multiple ‘parallel frames’ 
to articulate the mission and purpose of the CLAHRC to different stakeholders. That is, with 
some (local) audiences the CLAHRC was framed as meeting the needs of local 
commissioners, whilst with other (research) audiences a different narrative emphasised the 
portfolio of world-class studies and scientific publications.  
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Mobilising the new network 
 
In concert with drafting the bid, the regional leadership team commenced merging pre-
existing CLAHRC governance and administrative arrangements so they would ‘hit the 
ground running’ if funded.  
 
‘it allowed the two CLAHRCs to unfreeze and so … because they’d both been running 
for five years, they’ve both developed systems and structures that they thought were 
right…We spent a lot of time telling our funders how good we were but you know, we 
might have some things we were doing that probably weren’t working as well..’ (NHS 
Partner)  
 
The early phase of the new CLAHRC was shaped by sustaining the overarching narrative of 
collaboration through the formulation of a ‘Integration and Knowledge Mobilisation’ plan to 
bring the two ‘legacy’ CLAHRCs together within 100 days of funding.   
 
‘I’ve done quite a lot of mergers and they can be quite difficult. I said we needed an 
integration plan for the CLAHRC, which built on the strengths of both CLAHRCs, 
that’s actually in the prospectus. And produces something else that’s a step up. An 
integration plan actually looks at the two entities before they integrate and what the 
new entity is, that’s about organisational development and communications, keeping 
the good people, moving on one or two people who haven’t quite performed.’ (NHS 
Manager) 
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This involved formal inter-organisational contracts and memorandums of understanding, 
establishing an overarching communication strategy, and identifying local service 
collaborators. However, this integration plan gives few clues to the underlying tensions, such 
as the different working meanings of collaboration or the cultures of research. 
 
‘We did have a slightly torrid time in the beginning because we worked very, very 
differently. [CLAHRC A] had done a lot of work one set of priorities. So, we’ve taken 
some of the projects forward. [CLAHRC B] had done quite a lot on other issues and 
also in terms of the implementation strategy it was very strong. So, we’ve capitalised 
on that you know.’ (Research Theme Lead) 
 
Although the bid document presented a strong narrative of “a close relationship with the 
AHSN”, as the CLAHRC mobilised its relationship with the AHSN remained unclear. One 
prominent issue, for example, was the boundary between implementation ‘research’ and 
implementation ‘into practice’; with some taking the view that the CLAHRC was responsible 
for evidencing the effectiveness of interventions in local practice whilst the AHSN was 
responsible for translating the proven interventions into other practice settings. For some, the 
role of these organisations was presented as well aligned and complementary. 
 
‘Well it’s interesting and the CLAHRC works very well. We probably have the best 
partnerships of all the AHSN-CLAHRCs in the country. And this is historically 
because they understood CLAHRCs because their leader was a CLAHRC director 
previously.’ (Research Theme Lead) 
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There was a broader uncertainty about the CLAHRCs implementation function. Whilst 
national policies emphasised the importance of translational research, the NIHR stipulated 
that its funding could not be used for implementation (although it could be used for 
implementation research), with the expectation that partner organisations and the AHSN 
should fund longer-term implementation. For some, this reinforced a more traditional linear 
model of research where implementation activities occur after an intervention has indicated 
effectiveness; whilst others maintained that implementation planning should be considered 
with partners early in the research life-cycle to inform on-going study design and translation 
into practice. Research teams continually expressed a desire for more ‘implementation 
support’ especially to better understand and apply the principles of co-production to their 
study areas. Interview participants described the Implementation Theme as having low 
visibility within the CLAHRC and as having less influence (and funding) when compare to 
the ‘clinical’ themes. As such, many research teams relied on more traditional forms of 
dissemination, rather than the types of approaches expected in national policy.  
 
‘First of all we shouldn’t be doing implementation, NIHR were clear about it. We 
should not be doing implementation. AHSN are the people to do the implementation. 
Having said that, we do help to facilitate implementation, so we get the product ready 
for implementation. We don’t implement ourselves. We do have this disconnect that 
you know, we’re trying to do implementation but NIHR doesn’t pay for 
implementation at all. We are supposed to do world-class research and then work 
with our partners to get that implemented and disseminated.’ (Research Theme Lead) 
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For some, the narrative that ‘researchers don’t implement’ became a prominent sub-frame 
within the CLAHRC, reflecting the different research cultures that persisted across the 
region.  
 
Participant 10 ‘Because I’ve always said this: researchers don’t implement, that’s 
not their skillset, and I think to expect researchers to come in to CLAHRC, take a two-
year contract, do some funding to do a piece of research, then implement as well, it’s 
very unrealistic.’ (Network Manager) 
 
The responsibility for implementation remained a contentious issue and division within 
CLAHRC. For some, implementation activities were viewed as involving a skill-set that few 
traditional health researchers had acquired, and yet, a narrative persisted that implementation 
should be embedded throughout the work of the projects. For some, this conflicted with the 
expectation that the CLAHRC should produce ‘world-class’ research, especially where 
formative feedback and co-production was seen as comprising the scientific rigour of trial-
based studies. 
 
Discussion  
Our study examines how the ‘elite’ CLAHRC narrative, as articulated by national policy-
makers and manifest in official reports, was interpreted by regional actors in the context of 
their local histories and narratives of applied health research, and how the interplay between 
these elite and local narratives presented both dilemmas and opportunities for meaningful 
practices in the translation of policy into practice. In developing our analysis, we turn to the 
concept of framing to understand how policy actors (re-)frame the elite and local CLAHRC 
narratives, and how the translation of policy into practice occurs through a succession of 
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framing and re-framing activities through the communicative and interactive practices of 
policy actors. In other words, we suggest that it is through the interactive practice of framing 
that policy and local narratives are brought together, translated and re-made.  
 
As outlined above, the national policy narrative brought together multiple competing 
imperatives (i.e. world-class research, local health benefit, economic benefit) in what might 
be seen as a ‘master frame’ (Snow and Benford 1992) of ‘collaboration’ that set the broad 
parameters for how ‘local’ policy actors were expected to make sense of and enact national 
policy. We found, for example, that the broad narrative of ‘collaboration’ (along with 
‘maturity’) was operationalised by policy actors both in their ‘upwards’ relationship with 
national funders and their ‘downwards’ (or lateral) relationships with local policy actors. 
However, as this master frame permeated through the regional research landscape it was re-
interpreted in the context of pre-existing frames and also re-framed as policy actors, 
operating at different levels, negotiated the rationality and meaning of collaboration in the 
context of their diverse traditions (i.e. regional NHS and university leaders, CLAHRC senior 
leadership, and project teams). Although the master frame of collaboration might appear 
coherent, it was refracted and split into multiple ‘parallel frames’ that seemed simultaneously 
consistent with the overarching frame, whilst also allowing for the divergent interpretations 
of local stakeholders according to their own traditions.  
 
Elaborating this idea, we interpret the implementation of national policy into local contexts as 
a form ‘cascade’ framing, whereby the policy ‘master frame’ sets the broader direction of 
change (or ‘flow’), but where the meaningful practices of local actors repeatedly transform or 
divert elements of this frame in the context of their local traditions, resulting in the formation 
of parallel ‘local action frames’. These parallel local frames flow in the same broad direction 
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of policy implementation through adhering, in part, to the overarching master frame whilst 
also enabling groups of actors to mobilise in parallel ways according to their local customs 
(see Figure 1). 
 
<Insert Figure 1 About here> 
 
 
An important finding from our study was the apparent lack of clarity in the national ‘master 
frame’ which allowed for subsequent parallel re-framing at regional and local levels.  The 
high-level narrative was unclear in at least three areas.  Firstly, whether CLAHRCs should be 
concerned with undertaking world-class research (which often equates to large trials) or 
applied research that focuses on (making a difference to) local service providers.  Secondly, 
whether research should address national priorities for health improvement and economic 
growth, or the local service priorities and health needs.  Thirdly, whether translation and 
implementation activities are something that occurs independent of, and often at the end of 
the research process, or rather whether implementation should be integrated into the co-
production of research. As such, internal contradictions and inconsistencies in the elite 
narrative, as framed within policy, created the dilemmas around which re-framing occurred. 
 
Some commentators suggest CLAHRCs can reconcile these tensions through a coherent 
narrative in which they undertake world-class research that simultaneously addresses national 
and local priorities, and where this research is developed and implemented in a variety of 
local contexts (Caldwell and Mays, 2012).  Our study suggests, however, that these tensions 
within the CLAHRC narrative were not always easy to reconcile, and that evident variations 
in how CLAHRCs have evolved across the country (Rycroft-Malone et al. 2013) might be 
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explained by how policy actors working at different levels interpret and reconcile these 
tensions. In our study, this was manifest through the persistence of parallel frames at the 
regional and local levels that continued to drive local practices in different directions, but 
which to some extent offered a coherent, albeit unstable, overriding narrative to satisfy the 
expectations of national elites. Despite the potential for these parallel frames to disrupt the 
national mobilisation of CLAHRCS, regional leaders were successful in weaving together the 
national and local narratives to iteratively create a modified regional frame that would allow 
local ‘parallel frames’ to co-exist, whilst still meeting national expectations. The blending of 
these parallel frames was evidenced through the creation of the ‘integration and knowledge 
management plan’.  
 
Although the idea of cascade framing might lead to a view of policy translation that implies a 
linearity in the ‘downward’ implementation of national policy objectives at the local level 
(Caldwell and Mays (2012), our study shows that this is a recursive re-framing process, 
especially at the meso-regional level, where national policy imperatives and local parallel 
frames are continually mediated and aligned through creative re-framing.  Looking beyond 
our case study, our paper brings to light the need to look at how national and local narratives 
for research can be inconsistent in themselves, and at odds with one another.  Local narratives 
are influenced by distinct interpretive frames that reflect and create internal and external 
dilemmas around which different meanings and agendas become mobilised, as sites or 
opportunities for crafting new governing arrangements. Although senior research leaders 
clearly have an influential role in shaping the resultant narrative (Lockett et al. 2014), what 
seems equally important is the interplay of meanings amongst multiple networked actors, 
such as university and NHS leaders and other research partners. More than this, however, are 
broader social, cultural and political imperatives, especially the need to be seen as fair in the 
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distribution of roles and resources, and legitimate in terms of reflecting the best interests of 
local people and drawing on the best talents within the region. These issues extend the range 
of contextual factors previously shown to influence the formation of collaborative research 
networks (Rycroft-Malone et al. 2013). Looking outside of healthcare, the study also suggests 
that large-scale research infrastructure and programmes, in which the state is one of multiple 
actors, can be interpreted as sites in which divergent meanings about the purposes and 
processes of knowledge creation and application are contested, not only around different 
methodological traditions, but also around the desired economic and commercial benefits of 
research to the state (and national economy) and to industry (and shareholders). 
 
Finally, our paper demonstrates how the study of the framing perspective can enrich a 
decentred analysis of narratives (Bevir 2011). The concept of frames brings to light the webs 
of belief or traditions through which actors interpret and enact policy developments; whilst 
framing also highlights the interactive and communicative practices through which policy 
actors seek to influence others around policy agenda (Benford and Snow 2000). In one 
respect, therefore, attention to framing offers a lens for looking at the interplay between 
narratives and meaningful practice (Olsen 2014), where narratives are both source of tradition 
and dilemmas. The framing literature highlights, for example the role of ‘narratives’ or 
stories as rhetorical devices, whilst appeals to tradition and custom are also used to align 
actors to particular agenda (Fairhurst and Sarr 1996). As such, we suggest framing theory 
offers an important lens for understanding how meaningful practices experience, translate 
and enact policy narratives.  
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